Haemonetics | HAE - Operating Profit


Haemonetics reported $67.4M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD -31M 243.8M Mar/2026
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
ResMed USD 505.67M 8.07M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Surmodics USD 58K 5.7M Jun/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
US Physical Therapy USD 12.41M 4.35M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026